Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
暂无分享,去创建一个
[1] Cynthia J. Musante,et al. A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need , 2019, CPT: pharmacometrics & systems pharmacology.
[2] I. Zineh,et al. A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development , 2019, CPT: pharmacometrics & systems pharmacology.
[3] Alex Phipps,et al. Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network , 2019, CPT: pharmacometrics & systems pharmacology.
[4] Fan Wu,et al. Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape , 2018, CPT: pharmacometrics & systems pharmacology.
[5] DA Lauffenburger,et al. GPS for QSP: A Summary of the ACoP6 Symposium on Quantitative Systems Pharmacology and a Stage for Near‐Term Efforts in the Field , 2016, CPT: pharmacometrics & systems pharmacology.
[6] S. Marshall,et al. Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation , 2016, CPT: pharmacometrics & systems pharmacology.
[7] S. Visser,et al. Implementation of Quantitative and Systems Pharmacology in Large Pharma , 2014, CPT: pharmacometrics & systems pharmacology.
[8] Neil Benson,et al. Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development , 2011, Pharmaceutical Research.